Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vein Occlusion: later-stage trial registry
1 of 3 indexed Vein Occlusion trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Vein Occlusion: 3 US clinical trials tracked, 1 recruiting.
Vein Occlusion is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is W.L.Gore & Associates, running 2 of these trials.
Enrollment posture brief
Registry condition vein-occlusion
OPEN 1 | RECR 33% | LATE 1 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Vein Occlusion lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vein Occlusion on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vein Occlusion is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
W.L.Gore & Associates
NCT05489588
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
W.L.Gore & Associates
NCT05409976
Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery
Unity Health Toronto
NCT03900026
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Vein Occlusion records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vein Occlusion trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vein Occlusion page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Vein Occlusion trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- W.L.Gore & Associates sponsors the most Vein Occlusion trials on record, review their full trial history before evaluating a specific study. See W.L.Gore & Associates's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vein Occlusion condition card totals 3 registered trials; most-linked intervention GORE® VIAFORT Vascular Stent; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.